Effect

AOFAS Awards More Than $250,000 in Grants to Fund Foot and Ankle Orthopaedic Research

Retrieved on: 
Tuesday, March 26, 2024
Emory University, Diagnosis, Success, Red carpet, Early Career Award, Resident, Safety, Knowledge, Research, Effect, Foot, Ankle, Key, Gait analysis, Health, Pharmaceutical industry

Rosemont Ill., March 26, 2024 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) awarded its annual research grants to 9 promising foot and ankle research projects.

Key Points: 
  • Rosemont Ill., March 26, 2024 (GLOBE NEWSWIRE) -- The American Orthopaedic Foot & Ankle Society (AOFAS) awarded its annual research grants to 9 promising foot and ankle research projects.
  • With funding from the Orthopaedic Foot & Ankle Foundation , the AOFAS Research Grants Program provides AOFAS members and their research teams with the resources to discover new foot and ankle treatments and advance patient care.
  • “The AOFAS Research Grants Program supports foot and ankle orthopaedic surgeons’ important work with basic, translational, and clinical science,” said AOFAS Research Committee Chair Jason T. Bariteau, MD, from Emory University in Atlanta.
  • The AOFAS Research Grants Program is funded by the Orthopaedic Foot & Ankle Foundation, supported in part by a grant from Arthrex, Inc.

Adobe Introduces Next Generation of Frame.io To Accelerate Content Workflow and Collaboration for Every Creative Project

Retrieved on: 
Tuesday, April 9, 2024
Data Management, Technology, Online, Mobile Entertainment, TV and Radio, Mobile, Wireless, Apps, Applications, Podcast, Film & Motion Pictures, Entertainment, General Entertainment, Communications, Media, Other Technology, Audio, Video, Social Media, Influencer, Software, Blogging, Internet, Cloud, ADBE, Creative Review, IPad, Organization, IPhone, Filter, Workfront, Character, NAB, Blog, Photography, Team, Enterprise, EE Limited, Adobe Creative Cloud, Workflow, Effect, Adobe Premiere Pro, Multimedia, Adobe Photoshop, NAB Show, Metadata, Video game

Today, Adobe (Nasdaq: ADBE) introduced the all-new Frame.io V4 , a flexible, fast and intuitive creative collaboration platform that streamlines and simplifies workflows across content creation and production.

Key Points: 
  • Today, Adobe (Nasdaq: ADBE) introduced the all-new Frame.io V4 , a flexible, fast and intuitive creative collaboration platform that streamlines and simplifies workflows across content creation and production.
  • “As the demand for all content types – from video and images to design and documents – continues to skyrocket, the needs of Frame.io’s community have evolved.
  • While more content is being produced than ever before, creatives involved at all stages of development still experience disconnected and broken processes.
  • To learn more about other innovations available with Frame.io V4, visit the Frame.io blog here and view Frame.io V4 video here .

CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy

Retrieved on: 
Saturday, April 6, 2024
Guillain–Barré syndrome, Bone marrow, Medical College of Wisconsin, Encephalopathy, Survival, Immunotherapy, BCMA, Patient, Hypotension, Mortality, B-cell maturation antigen, Edema, Periodic breathing, Associate professor, Dexamethasone, Certification, Neutropenia, Dizziness, Risk, Headache, Chills, Myelodysplastic syndrome, Coagulopathy, DPD, Johnson & Johnson, Immune system, Effect, Fatigue, Thrombocytopenia, Food, Disease, Drive, Appetite, Lymphocytopenia, JNJ, Constipation, Multiple myeloma, Acute myeloid leukemia, CRS, Death, Hypersensitivity, Cytopenia, Cytokine release syndrome, ASCO, Use, Hematology, FDA, PVD, Annual general meeting, T cell, DSM-IV codes, Incidence, Tachycardia, Bortezomib, Diarrhea, Viral, Hope, United, Cough, Daratumumab, Nausea, Society, Division, Physician, Pharmaceutical industry

HORSHAM, Pa., April 5, 2024 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has approved CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) for the treatment of adult patients with relapsed or refractory multiple myeloma who have received at least one prior line of therapy, including a proteasome inhibitor and an immunomodulatory agent, and are refractory to lenalidomide.1 With this approval, CARVYKTI® becomes the first and only B-cell maturation antigen (BCMA)-targeted therapy approved for the treatment of patients with multiple myeloma as early as first relapse.

Key Points: 
  • "This milestone underscores our commitment to improve outcomes for patients and transform the treatment of multiple myeloma with CARVYKTI," said Jordan Schecter, M.D., Vice President, Disease Area Leader, Multiple Myeloma, Johnson & Johnson Innovative Medicine.
  • CARVYKTI® is a cell therapy that works by harnessing a patient's immune system, or T cells, to fight the disease.
  • Treatment requires extensive training, preparation, and certification to ensure a positive experience for patients.
  • Since initial approval in February 2022, Johnson & Johnson has made significant advances in manufacturing to rapidly scale CARVYKTI® production.

US monetary policy is more powerful in low economic growth regimes

Retrieved on: 
Tuesday, April 2, 2024
Tao, Research Papers in Economics, Excess, American Economic Journal, Doan, Policy, RT, Interpolation, Economic growth, Absorption, Business, E32, Low, Browning, European Economic Review, UST, NBER, Forecasting, Macroeconomics, European Economic Association, Journal of Monetary Economics, Journal of Applied Econometrics, TVAR, Oxford University Press, Time series, Economic Inquiry, Paper, Linearity, Joshua Angrist, Nobuhiro, Environment, Political economy, Journal of Financial Economics, Rated R, R2, Website, Emi, Energy economics, Probability, Medical classification, Eurozone, Sigismund, Quarterly Journal of Economics, Zero lower bound, History, Nature, Chapter, ZT, Journal of Political Economy, Bocconi University, OLS, Statistics, University of California, Irvine, PDF, Classification, ECB, XS, ITP, Impact, Estimation, DGP, Mark Thoma, Social science, Elsevier, JEL, Cambridge University Press, Real, M1, Research, Textbook, Private sector, FED, Credit, UTT, Literature, Federal Reserve, Knotek, Evelyn Regner, Table, European Central Bank, Chow, FRED, Monetary economics, Wald, Ben Bernanke, Premium, P500, BIS, EWMA, International Economic Review, Federal funds rate, Money, Treasury, C32, The Economic Journal, Federal Reserve Economic Data, Employment, Risk, FFR, Suggestion, FOMC, Monte Carlo method, Sigmoid, VAR, Database, Projection, Ascari, The Journal of Finance, Yield curve, United States Treasury security, Economy, Fed, Figure, NFCI, Financial economics, EXP, Freedom, Central bank, PCE, Monetary policy, American Economic Review, Exercise, Interest, Samuel, URR, Rigidity, Business cycle, XT, Landing slot, Chap, Daron Acemoglu, Markov, Blue chip, Kuttner, Response, Quarterly Journal, YT, Channel, GDP, Standard, Effect, Federal, Cost, Christian Social Union (UK), Journal of Econometrics, Comm, Mark Gertler, Use, Economic statistics, IW, Bank for International Settlements, Finance Secretary (India), UC, Bank, Reproduction, Section, News, Housing, Data, Food industry
Key Points: 

    Business as usual: bank climate commitments, lending, and engagement

    Retrieved on: 
    Tuesday, April 2, 2024
    Smoke, Carbon, Pillar, Worldwide, BPER, Employment, Disclosure, Economic methodology, LEI, Research Papers in Economics, CGD, Ibercaja Banco, Fossil, Mediobanca, Policy, UNEP, Crédit Mutuel, BBVA, Columbia Business School, Pari, Corporate finance, NBER, Principle, Agriculture, Société Générale, Insurance, Allied Irish Banks, Medical classification, Aluminium, Becker, Feedback, Central bank, Triodos Bank, Target, Prosocial behavior, Journal of Financial Economics, European Parliament, MIT, R2, Website, Behavior, Poisson, Human, UN, Climate, Crédit Agricole, United Nations, Transport, Coal mining, Syndicated loan, Investment, ABN AMRO, Politics, BSI, OLS, PDF, ECB, Unemployment, Econometrics, Ambition, Clutch (eggs), IEA, Social science, Engagement, JEL, Climate change, Risk management, Yb, Bias, Abanca, Research, Classification, UniCredit, A.5, NZIA, Divestment, Literature, IPCC, European Central Bank, AA, Geography, Natural gas, Green lending, Metal, The Borrowers, Elasticity, Stanford Social Innovation Review, Steven M. Greer, BMPS, Finance, Risk, Single, CaixaBank, PPML, BNP Paribas, European, Money, NLB Group, La Banque postale, Corporate welfare, Paris Agreement, A.2, ROW, OECD, Fraud, Coal, Frustration, Iron, Commerzbank, Bank of Åland, COP, Comparison, Overalls, All, Temperature, Banca Ifis, Conference, Pressure, Steel, International Energy Agency, United, Alpha Bank, Interest, SSRN, Justice, AAA, Deutsche Bank, Crawford, Science Based Targets initiative, GFANZ, Quarterly Journal, Rabobank, Hirschman, Effect, Carbon Disclosure Project, ESG, MSCI, Support, NZBA, Sierra Club, Map, Taxonomy, Q50, Banco Sabadell, Financial Times, Banco BPM, BPCE, Reproduction, Erste Group, Data, G21, Interval (mathematics), Cardboard
    Key Points: 

      Healthy Foods Deliver Defense Against Cancer and Heart Disease

      Retrieved on: 
      Wednesday, February 21, 2024
      Buffalo, Blood pressure, Diabetes, Breast cancer, Consumer, Effect, Copper, Research, Magnesium, Zinc, Cholesterol, Blood, Obesity, Mineral, Food, Vitamin, Weight loss, Glycemic, Prostate, Plant, Harvard University, Purdue University, Conditional sentence, Exercise, Plaque, Human body weight, Phytosterol, Niacin, Risk, Potassium, Vitamin E, Seed, Types of plant oils, Radiation, Olive oil, Health, Folate, University, Death, Nutrient, Fasting, Medicine, Artery, Physiology, Heart, Resveratrol, Food industry, Pinterest, Meal, Brain, Fats, HDL, Cancer, Randomized controlled trial, Dietary supplement

      The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.

      Key Points: 
      • The vitamins and minerals in "good-for-you" nourishment provide energy for daily living, help the body grow and repair and can prevent diet-related illnesses like cancer and heart disease.
      • According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed by cancer.
      • There are a number of factors that can increase the risk of developing heart disease, including high blood pressure, high cholesterol, obesity and diabetes .
      • Research shows that in addition to inhibiting colon, prostate and breast cancer cell growth, they can also protect against heart disease.

      bibigo™ Invites Fans to Pay for Their Dumplings by Singing With Checkout Karaoke

      Retrieved on: 
      Wednesday, January 24, 2024
      Entertainment, Advertising, Online, Communications, General Entertainment, Food, Beverage, Social Media, Music, Retail, Influencer, Social media, Central Time, Multimedia, CJ, Friends, Prize, Love, Singing, Internet celebrity, Effect, Human, Marketing, CJ CheilJedang, Online shopping

      1 brand of dumplings in the U.S., is inviting fans to show their love for their favorite bibigo™ products by singing karaoke to pay for them.

      Key Points: 
      • 1 brand of dumplings in the U.S., is inviting fans to show their love for their favorite bibigo™ products by singing karaoke to pay for them.
      • To make sure everyone can rise to the occasion, the brand is bringing their machine to the digital space through the TikTok filter named bibigo™ Checkout Karaoke.
      • On top of being a tempting proposition, it is an invitation for the world to celebrate three staples of Korean culture: karaoke, dumplings and K-pop.
      • To learn more about bibigo™ Checkout Karaoke, please visit the bibigo™ TikTok page to follow the recent posts: https://www.tiktok.com/@bibigousa

      Jodi Manning Appointed as CEO of Cool Effect

      Retrieved on: 
      Thursday, January 18, 2024
      Environment, Manufacturing, Alternative Energy, Green Technology, Energy, Environmental Health, Other Manufacturing, Carbon, Manning, Ogilvy (agency), Ogilvy, Health, Publicis, Multimedia, Effect, COP21, Creative director, Jodi, Cool, Fortune 500, Marketing, Cool Effect, SVP, Growth

      Cool Effect , a Bay Area-based nonprofit dedicated to supporting carbon projects around the globe, is announcing today that long-time executive Jodi Manning has been promoted to Chief Executive Officer (CEO), effective immediately.

      Key Points: 
      • Cool Effect , a Bay Area-based nonprofit dedicated to supporting carbon projects around the globe, is announcing today that long-time executive Jodi Manning has been promoted to Chief Executive Officer (CEO), effective immediately.
      • View the full release here: https://www.businesswire.com/news/home/20240118254329/en/
        Long-time executive Jodi Manning has been promoted to Chief Executive Officer (CEO) of Cool Effect, a Bay Area-based nonprofit dedicated to supporting carbon projects around the globe.
      • Most recently, Jodi served as VP, Marketing and Corporate Partnerships for Cool Effect.
      • As we face the urgent need for environmental action, high quality carbon projects are simultaneously helping the planet and creating good on the ground in the places that need it most,” said Jodi Manning, newly appointed CEO of Cool Effect.

      Maxon Red Giant Update Delivers Fast, Beautiful Bokeh and Realistic Lens Flares

      Retrieved on: 
      Wednesday, January 17, 2024
      Cloud, Giant, Human physical appearance, UE, BAD, Life, Magic bullet, Tracker, Particular, Form, Effect, Unreal Engine, Red giant, VFX, Video game

      BAD HOMBURG, Germany, Jan. 17, 2024 /PRNewswire-PRWeb/ -- Maxon, developers of professional software solutions for editors, filmmakers, motion designers, visual effects artists, and creators of all types, today announced wide-ranging updates to Red Giant 2024.

      Key Points: 
      • Universe offers editors and compositors an essential toolkit of effects and transitions and now it's even easier to add dream bokeh to any shot.
      • New Bokeh plugin allows artists to quickly create beautiful bokeh and mimic camera focus without the need for a complex camera lens setup.
      • Bokeh Transition, a variant of the Bokeh plugin, helps artists seamlessly transition between two clips using a dazzling de-focus effect.
      • Highlighting Trapcode's new cloud service support, Maxon has added two new sprite categories for emojis and pixel art.

      Landos Biopharma to Present New Data on Immunometabolism at the 19th Annual Congress of the European Crohn’s and Colitis Organisation

      Retrieved on: 
      Monday, January 8, 2024
      Human, Treatment, Chronic pain, Homeostasis, PLXDC2, Ulcer, Disease, UC, Doctor of Philosophy, ECCO, Pharmacokinetics, NLRX1, Abstract, UZ Leuven, Library, Congress, European, Effect, Inflammatory Bowel Diseases, Inflammation, Patient, Translation, Immunometabolism, Safety, Landos, NEXUS, Pharmaceutical industry

      The abstracts highlight new and additional data on immunometabolism modulation by activating NLRX1 and PLXDC2 with novel agonists such as NX-13 and LABP-69.

      Key Points: 
      • The abstracts highlight new and additional data on immunometabolism modulation by activating NLRX1 and PLXDC2 with novel agonists such as NX-13 and LABP-69.
      • The ECCO congress will take place February 21-24, 2024 in Stockholm, Sweden.
      • We are excited to present data from multiple studies including the impact of NX-13 on eosinophil infiltration and visceral hypersensitivity, as well as confirming its relevancy in multiple models and species.
      • Additionally, we are pleased to share new preclinical insights into the potential role of PLXDC2 in ulcerative colitis,“ said Fabio Cataldi, M.D., Executive Vice-President & Chief Medical Officer at Landos.